Leonia, NJ, United States of America

Lida Qi


 

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 30(Granted Patents)


Location History:

  • Leonia, NJ (US) (2002 - 2012)
  • Killingworth, CT (US) (2013)

Company Filing History:


Years Active: 2002-2013

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Lida Qi: Innovator in JNK Inhibitors

Introduction

Lida Qi is a prominent inventor based in Leonia, NJ (US), known for her significant contributions to the field of medicinal chemistry. With a total of nine patents to her name, she has made remarkable strides in developing compounds that target specific biological pathways.

Latest Patents

Among her latest innovations are two notable patents related to JNK inhibitors. The first patent focuses on aminomethyl quinolone compounds, which are designed to inhibit JNK and provide methods, formulations, and compositions for treating JNK-mediated disorders. The compounds disclosed in this patent are useful for modulating JNK activity and addressing diseases associated with its dysfunction. The second patent also pertains to adamantyl compounds, which similarly aim to inhibit JNK and offer therapeutic solutions for related disorders. Both patents emphasize the importance of these compounds in medical applications and outline processes for their synthesis.

Career Highlights

Lida Qi has worked with esteemed organizations, including Hoffmann-La Roche Inc. and the United States Navy. Her experience in these institutions has allowed her to collaborate on various innovative projects, further enhancing her expertise in the field.

Collaborations

Lida has collaborated with notable colleagues, including Kevin Richard Guertin and Adrian Wai-Hing Cheung. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Lida Qi's work in developing JNK inhibitors showcases her dedication to innovation in medicinal chemistry. Her patents reflect her commitment to addressing critical health issues through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…